Schedule 13G ownership disclosure
Keros Therapeutics Inc
COMMON STOCK · CUSIP: 492327101
Event date: 2025-01-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 704,472.00 · Class: 1.7%
- Abigail P. Johnson
Shares: 704,472.00 · Class: 1.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-000428
- Form type
- SCHEDULE 13G/A
- Filer
- FMR LLC
- CIK
- CIK 315066
- Filed
- Feb 07, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership